Oculera Sağlık Teknolojileri A.Ş.
Türkiye TR-MF-000039722 Last updated 17 Sep 2026
- Devices
- 1
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
EUDAMED certificates
Notified body 1984 1 certificate
- 1984-MDR-00018924 Issued
Quality management system EU MDR
- Issued
- 24 Oct 2025
- Expires
- 23 Oct 2030
Related companies
Notified bodies
- Notified body 1984
About
Oculera VR Perimeter (Visual Field Analyzer) is compact and powerful, meeting all your clinical and screening needs. Ideal for use in hospitals, optometry practices, and optical shops.
What Oculera Sağlık Teknolojileri A.Ş. makes
Oculera Sağlık Teknolojileri A.Ş. manufactures the Oculera Visual Field Analyzer, a device used for assessing visual field testing in clinical and screening settings. It is designed for use in hospitals, optometry practices, and optical shops to evaluate patients' peripheral vision.
The Oculera Visual Field Analyzer is classified as a Class IIa medical device and is registered in the EU’s eudamed database. The company is based in Turkey.
Frequently asked questions
What types of medical devices does Oculera Sağlık Teknolojileri A.Ş. manufacture?
Oculera Sağlık Teknolojileri A.Ş. manufactures the Oculera Visual Field Analyzer, a device specifically designed for visual field testing. This device is used in clinical and screening settings to assess patients' peripheral vision, making it suitable for hospitals, optometry practices, and optical shops.
Where is Oculera Sağlık Teknolojileri A.Ş. based?
The company is based in Turkey, as indicated in its regulatory and operational details.
Which regulatory registries list Oculera’s devices?
The Oculera Visual Field Analyzer is registered in the EU’s eudamed database, which is the centralised EU registry for medical devices. This registration helps ensure transparency and traceability of the device within the European market.
How are Oculera’s devices classified under medical device regulations?
The Oculera Visual Field Analyzer falls under Class IIa classification, which is determined based on its intended purpose and associated risk level. Class IIa devices typically require conformity assessment procedures, such as a notified body review, to ensure their safety and performance before being placed on the market.
Information
- Country
- Türkiye
- Address
- 100.Yil Bulvari Cd., Ostim Organize Sanayi Bölgesi , Ankara, Türkiye
- Website
- www.oculera.health/
- [email protected]
- PRRC contact
- Mervecan Gökçe
- EUDAMED SRN
- TR-MF-000039722